Colorectal Cancer Detected by 1H-NMR Spectroscopy (BIOCOR)
Metabolic Phenotyping of Blood Plasma by Means of 1H-NMR Spectroscopy: a New Tool to Detect Colorectal Cancer?
研究概览
详细说明
Colorectal cancer is one of the most common and deadliest cancers worldwide. Since tumor stage at time of diagnosis is a critical determinant of patient outcome, early detection of colorectal cancer by screening modalities holds the key to improving patient survival. However, current tests, i.e. fecal occult blood testing and colonoscopy, are inadequate for first line screening of colorectal cancer due to limited accuracy and low participation rates, respectively. Therefore, there is an urgent need for new and accurate tests that can be used for en masse screening of colorectal cancer. A blood-based test represents a promising alternative as it takes little time, poses minimal risk to the patient, and is therefore very likely to lead to high participation rates. The development of an effective blood-based screening tool is based on the identification of biomarkers in the blood that are sensitive and specific for colorectal cancer. Studying the metabolic phenotype of colorectal cancer may help to identify such biomarkers since the metabolism of cancer cells is known to differ significantly from that of normal cells. More specifically, the entire metabolism of cancer cells is reprogrammed to increase anabolic reactions that favor cell growth and cell survival.
The hypothesis of the present study is that metabolic phenotyping of blood plasma allows to (i) discriminate between colorectal cancer patients and control subjects and (ii) identify new biomarkers for colorectal cancer. In order to test this hypothesis, The investigators will apply proton nuclear magnetic resonance (1H-NMR) spectroscopy to perform metabolic phenotyping of blood plasma in 50 colorectal cancer patients and 50 control subjects. Multivariate statistics will be performed to assess the discriminative power of the applied methodology in distinguishing between both groups and to identify metabolites with potential as biomarkers for colorectal cancer.
研究类型
注册 (实际的)
联系人和位置
学习地点
-
-
-
Genk、比利时、3600
- Ziekenhuis Oost-Limburg
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
取样方法
研究人群
描述
Inclusion Criteria:
- The subject has undergone a colonoscopy or is scheduled to undergo a colonoscopy in the future
- The subject is aged between 40 and 90 years
- The subject understands the study-specific procedures and provides written informed consent before any study-specific procedures are performed
Exclusion Criteria:
- No fasting starting from 10 p.m. the day prior to blood sampling
- Medication intake on the morning of blood sampling
- Diabetes
- History of cancer during the past 5 years
- Treatment for cancer during the past 5 years
- Inflammatory bowel disease
学习计划
研究是如何设计的?
设计细节
队列和干预
团体/队列 |
干预/治疗 |
|---|---|
|
Control group-Blood sampling
-subjects with a normal colonoscopy
|
Determine the metabolic phenotype of blood plasma by NMR spectroscopy
其他名称:
determine amount and type of free circulating miRNA in blood plasma
其他名称:
|
|
Study group-Blood sampling
- subjects with colorectal cancer after colonoscopy
|
Determine the metabolic phenotype of blood plasma by NMR spectroscopy
其他名称:
determine amount and type of free circulating miRNA in blood plasma
其他名称:
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
metabolic phenotype of colorectal cancer
大体时间:day 1
|
Significant metabolic changes in blood plasma of colorectal cancer patients compared with control subjects
|
day 1
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
tumor histology
大体时间:day 1
|
subtype of histology of the colorectal tumor (according to WHO histological classification of tumors of the colon and rectum)
|
day 1
|
|
tumor stage
大体时间:Day 1
|
stage of the colorectal tumor, defined by the TNM classification system (7th edition)
|
Day 1
|
合作者和调查者
调查人员
- 学习椅:peter Adriaensens, prof. dr.、Hasselt University
- 首席研究员:Michiel thomeer, prof. dr.、Ziekenhuis Oost-Limburg, Hasselt University
- 学习椅:Liesbet Mesotten, prof. dr.、Ziekenhuis Oost-Limburg, Hasselt University
- 学习椅:Philip Caenepeel, prof. dr.、Ziekenhuis Oost-Limburg, Hasselt University
- 学习椅:Kirsten Stinkens, dr.、Hasselt University
- 学习椅:Evelyne Louis, PhD student、Hasselt University
- 学习椅:Robby Louis, student、Hasselt University
出版物和有用的链接
一般刊物
- Beckonert O, Keun HC, Ebbels TM, Bundy J, Holmes E, Lindon JC, Nicholson JK. Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat Protoc. 2007;2(11):2692-703. doi: 10.1038/nprot.2007.376.
- Zhang A, Sun H, Yan G, Wang P, Han Y, Wang X. Metabolomics in diagnosis and biomarker discovery of colorectal cancer. Cancer Lett. 2014 Apr 1;345(1):17-20. doi: 10.1016/j.canlet.2013.11.011. Epub 2013 Dec 11.
- Wang H, Wang L, Zhang H, Deng P, Chen J, Zhou B, Hu J, Zou J, Lu W, Xiang P, Wu T, Shao X, Li Y, Zhou Z, Zhao YL. (1)H NMR-based metabolic profiling of human rectal cancer tissue. Mol Cancer. 2013 Oct 18;12(1):121. doi: 10.1186/1476-4598-12-121.
- Zavoral M, Suchanek S, Majek O, Fric P, Minarikova P, Minarik M, Seifert B, Dusek L. Colorectal cancer screening: 20 years of development and recent progress. World J Gastroenterol. 2014 Apr 14;20(14):3825-34. doi: 10.3748/wjg.v20.i14.3825.
- Ganepola GA, Nizin J, Rutledge JR, Chang DH. Use of blood-based biomarkers for early diagnosis and surveillance of colorectal cancer. World J Gastrointest Oncol. 2014 Apr 15;6(4):83-97. doi: 10.4251/wjgo.v6.i4.83.
- Louis R, Louis E, Stinkens K, Mesotten L, de Jonge E, et al. (2016) Metabolic Phenotyping of Blood Plasma by Proton Nuclear Magnetic Resonance to Discriminate between Colorectal Cancer, Breast Cancer and Lung Cancer. Metabolomics (Los Angel) 6: 187. doi: 10.4172/2153-0769.1000187
研究记录日期
研究主要日期
学习开始
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (估计)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.